AN2 Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
ANTX Nasdaq 8731 https://www.an2therapeutics.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AN2 Therapeutics Inc

AN2 Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights - Mar 29th, 2023 8:01 pm
AN2 Therapeutics to Participate in Upcoming Investor Conferences - Feb 28th, 2023 9:10 pm
AN2 Therapeutics to Present at SVB Securities Global Biopharma Conference - Jan 31st, 2023 9:10 pm
AN2 Therapeutics (NASDAQ:ANTX) Is In A Good Position To Deliver On Growth Plans - Dec 4th, 2022 1:40 pm
AN2 Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates - Nov 9th, 2022 9:05 pm
AN2 Therapeutics to Present at Upcoming Investor Conferences - Nov 2nd, 2022 8:10 pm
AN2 Therapeutics to Present New Epetraborole Data at IDWeek 2022 - Oct 19th, 2022 12:00 pm
AN2 Therapeutics Provides Update on Epetraborole Ex-U.S. Development Plan in Treatment-Refractory MAC Lung Disease - Oct 6th, 2022 11:00 am
NIH Awards Contract to AN2 Therapeutics Valued Up to $17.8 Million - Sep 29th, 2022 11:00 am
AN2 Therapeutics to Present at H.C. Wainwright 24th Annual Global Investment Conference - Aug 29th, 2022 11:00 am
AN2 Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Updates - Aug 11th, 2022 8:10 pm
What Type Of Shareholders Make Up AN2 Therapeutics, Inc.'s (NASDAQ:ANTX) Share Registry? - Aug 8th, 2022 3:42 pm
AN2 Therapeutics Initiates Pivotal Phase 2/3 Trial Evaluating Epetraborole for Treatment-Refractory MAC Lung Disease - Jun 29th, 2022 11:00 am
We're Not Very Worried About AN2 Therapeutics' (NASDAQ:ANTX) Cash Burn Rate - Jun 27th, 2022 1:19 pm
AN2 Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Updates - May 10th, 2022 8:10 pm
AN2 Therapeutics Appoints Maggie FitzPatrick to Its Board of Directors - May 9th, 2022 11:00 am